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Abstract
Background: Peripheral blood monocytes (PBMo) originate from the bone marrow, circulate in the blood and emigrate into
various organs where they differentiate into tissue resident cellular phenotypes of the mononuclear phagocyte system, including
macrophages (Mϕ) and dendritic cells (DC). Like in other organs, this emigration and differentiation process is essential to
replenish the mononuclear phagocyte pool in the lung under both inflammatory and non-inflammatory steady-state conditions.
While many studies have addressed inflammation-driven monocyte trafficking to the lung, the emigration and pulmonary
differentiation of PBMo under non-inflammatory conditions is much less understood.
Methods: In order to assess the transcriptional profile of circulating and lung resident mononuclear phagocyte phenotypes,
PBMo, lung Mϕ and lung DC from naïve mice were flow-sorted to high purity, and their gene expression was compared by DNA
microarrays on a genome-wide scale. Differential regulation of selected genes was validated by quantitative PCR and on protein
level by flow cytometry.
Results:  Differentially-expressed genes related to cell traffic were selected and grouped into the clusters (i) matrix
metallopeptidases, (ii) chemokines/chemokine receptors, and (iii) integrins. Expression profiles of clustered genes were further
assessed at the mRNA and protein levels in subsets of circulating PBMo (GR1- vs GR1+) and lung resident macrophages (alveolar
vs interstitial Mϕ). Our data identify differentially activated genetic programs in circulating monocytes and their lung
descendents. Lung DC activate an extremely diverse set of gene families but largely preserve a mobile cell profile with high
expression levels of integrin and chemokine/chemokine receptors. In contrast, interstitial and even more pronounced alveolar
Mϕ, stepwise downregulate gene expression of these traffic relevant communication molecules, but strongly upregulate a
distinct set of matrix metallopetidases potentially involved in tissue invasion and remodeling.
Conclusion: Our data provide new insight in the changes of the genetic profiles of PBMo and their lung descendents, namely
DC and Mϕ under non-inflammatory, steady-state conditions. These findings will help to better understand the complex
relations within the mononuclear phagocyte pool of the lung.
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Background
Peripheral blood monocytes (PBMo) can emigrate from
the blood through the endothelial barrier into various tis-
sues under both non-inflammatory, steady-state condi-
tions and in response to inflammatory stimuli. After
extravasation, PBMo undergo rapid phenotype changes
and differentiate into cells of the organ resident mononu-
clear phagocyte system, namely macrophages (Mϕ) and
dendritic cells (DC) [1,2]. This highly coordinated process
implicates close linkage between monocyte trafficking
and cellular differentiation, which shapes the phenotype
of the extravasated cells. Monocyte differentiation has
been extensively studied in vitro. Monocytes cultured in
medium containing macrophage colony-stimulating fac-
tor (M-CSF) differentiate into Mϕ, while in the presence of
granulocyte macrophage colony-stimulating factor (GM-
CSF) and Interleukin (IL) -4, monocytes differentiate into
DC [3,4]. Although recent in vivo investigations have dem-
onstrated that subsets of PBMo can be precursors for DC
and Mϕ [5,6], the detailed fate of PBMo once they leave
the circulation has not been comprehensively addressed.
Moreover, while cell recruitment under inflammatory
conditions has been extensively studied, the tissue migra-
tion and differentiation of mononuclear phagocytes
under non-inflammatory conditions remain poorly
understood.
In the lung, cells of the mononuclear phagocyte system
are key players in host defense and immunological home-
ostasis. While Mϕ are generally present in both the lung
interstitium and alveolar airspaces, DC are mainly located
within the interstitium with only a minor proportion
found at the respiratory tract surface areas [7,8]. In addi-
tion to their different localization, Mϕ and DC in the lung
fulfill distinct and specialized roles in the immune
response, which correlate with their different migration
properties and cellular phenotypes. In the absence of
inflammatory stimuli, DC have a much shorter half-life in
the lung compared to Mϕ [9]. Furthermore, DC do not
exhibit impressive phagocytic activity, but rather process
antigens which are then presented to T cells upon stimu-
lation, causing antigen specific T cell priming. To ensure
an effective antigen presentation to T cells, DC must
migrate to the regional lymph nodes. In contrast, Mϕ are
considered to form resident cell populations both in the
interstitium (interstitial macrophages, iMϕ) and in the
alveolar airspace (resident alveolar macrophages, rAM),
where they function as major sentinel and phagocytic
population of the lung for invading pathogens [10]. Alve-
olar macrophage and DC precursors must migrate from
the bloodstream through endothelial and epithelial barri-
ers into the alveolar compartment. This journey requires
the expression of genes involved in communication with
barrier structures and rapid adjustment to different oxy-
gen concentrations and osmotic pressures.
Trafficking of monocytes into lung tissue and their differ-
entiation into lung resident Mϕ and DC is supposed to be
regulated by the expression of specific gene clusters, which
promote cell-cell interaction, migration and matrix degra-
dation and the acquisition of tissue specific cellular phe-
notypes. Traffic related gene clusters include chemokines,
integrins, and tissue-degrading matrix metallopeptidases
(Mmps), for all of which members have been shown to be
functionally important. A complete picture, however, of
the gene clusters that are regulated during in vivo migra-
tion and differentiation of PBMo under non-inflamma-
tory conditions has not yet been obtained. Currently,
adaptive changes of cellular phenotypes cannot be
directly assessed by cell fate mapping during the slow traf-
ficking of mononuclear phagocytes to lung tissue under
steady-state conditions. Therefore, as an alternative
approach to gain a better insight into the genetic programs
that drive the mononuclear phagocyte migration and dif-
ferentiation processes, the transcriptomes of circulating
monocytes were compared with their lung tissue mono-
nuclear phagocyte progeny. By this approach, gene clus-
ters related to cell migration were identified and
confirmed by quantitative real-time PCR (qRT-PCR) anal-
ysis that are differentially expressed between PBMo versus
lung Mϕ and DC, and which shape the mononuclear
phagocyte phenotyes in the circulation and in the lung tis-
sue.
Methods
Mice
Experiments were performed with wild-type C57BL/6N
mice (six to nine weeks old), which were purchased from
Charles River (Sulzbach, Germany) and were maintained
under specific pathogen free conditions with free access to
food and water. All animal experiments were approved in
accordance with the guidelines of Institutional Animal
Care and Use Committee and were approved by the local
government authority.
Isolation of peripheral blood monocytes, lung 
macrophages and lung DC
Mice were sacrificed by an overdose of isoflurane inhala-
tion (Forene®, Abbott). Blood was collected from the vena
cava caudalis and aseptically transferred to 15 ml tubes.
Clotting was prevented by addition of EDTA. Erythrolysis
was performed with 10 ml 0.8% ammonium chloride
lysis buffer. Erythrolysis was stopped by addition of 5 ml
of RPMI-1640 medium supplemented with 10% FCS and
L-glutamine, and cells were centrifuged (400 × g, 10 min,
4°C). The pellet was re-suspended in 10 ml ammonium
chloride buffer, and the procedure was repeated. Cells
were then washed in 5 ml RPMI-1640 medium supple-
mented with 10% FCS and L-glutamine, resuspended in
PBS/2 mM EDTA/0.5% FCS, and stained for flow cytome-
try as outlined below.Respiratory Research 2009, 10:2 http://respiratory-research.com/content/10/1/2
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Macrophages and DC from lungs were isolated as
described in detail recently [8,11]. Briefly, lungs were per-
fused with 20 ml of sterile HBSS until free of blood by vis-
ual inspection, then removed and transferred into Petri
dishes containing 0.7 mg/ml collagenase A (Roche;) and
50 μg/ml DNAse I (Serva;) in RPMI-1640 medium. Lungs
were minced and cut into small pieces, agitated on a
shaker (30 min, RT) and then incubated at 37°C for 30
min in a humidified atmosphere containing 5% CO2. Cell
aggregates were dispersed by repeated passage through a
syringe, and filtered through a 200 μm and a 40 μm cell
strainer (BD Biosciences), to obtain single cell suspen-
sion. Subsequently, cells were rinsed with HBSS and PBS/
2 mM EDTA/0.5% FCS, followed by incubation with an
excess concentration of unspecific IgG (Octagam, Octap-
harma, Germany) to reduce non-specific antibody bind-
ing. After washing with PBS/2 mM EDTA/0.5% FCS, cells
were stained with magnetic bead-conjugated anti-CD11c
antibodies (Miltenyi Biotec) followed by magnetic separa-
tion according to the manufacturer's instructions. Subse-
quently, the cell population (containing CD11c positive
cells) was stained with CD11c-PE conjugated antibodies
(BD Pharmingen) and sorted as outlined below.
To obtain resident alveolar macrophages, bronchoalveo-
lar lavage (BAL) was performed with 500 μl aliquots of
sterile PBS/2 mM EDTA (pH 7.2) until a BAL fluid (BALF)
volume of 5 ml was recovered following previously
described protocols [12]. The BALF was centrifuged (400
× g, 10 min, 4°C); the cell pellet was resuspended in PBS/
2 mM EDTA/0.5% FCS, stained with CD11c PE conju-
gated antibodies (BD Pharmingen) and subjected to sort-
ing.
Flow cytometric analysis and flow sorting
For staining for flow cytometric analysis and sorting, cells
were resuspended in PBS/2 mM EDTA/0.5% FCS. Cell
numbers were assessed using a Neubauer chamber. Fc-
receptor-mediated and non-specific antibody binding was
blocked by addition of excess non-specific immunoglob-
ulin (Octagam®, Octapharma, Germany). The following
monoclonal antibodies were used at appropriate dilu-
tions for staining: CD11c-PE and -APC (HL3, BD
Pharmingen), CD11b-FITC, -APC, and -PE (M1/70, BD
Pharmingen), CD115-PE (604 B5 2EII, Serotec), GR-1-PE-
Cy7 and -PE (RB6-8C5, Biolegend), F4/80-PE (CI:A3-1,
Serotec), biotinylated I-A/I-E (2G9, BD Pharmingen),
CD3-PE (17A2, BD Pharmingen), CD19-PE (1D3, BD
Pharmingen), NK-1.1-PE (PK136, BD Pharmingen),
CD80-PE (1G10, BD Pharmingen), CD86-PE (GL1, BD
Pharmingen), B220-PE (RA3-6B2, BD Pharmingen),
CD49d-PE (R1-2, Biolegend), CD103-PE (2E7, Bioleg-
end), CD61-PE (2C9G2, Biolegend), Integrin β7 (FIB504,
Biolegend).
Staining was performed at 4°C in the dark for 20 min.
After staining, cells were washed twice in PBS/2 mM
EDTA/0.5% FCS. Biotinylated primary antibodies were
further incubated for 5 min with APC-conjugated strepta-
vidin (BD Pharmingen), followed by two additional
washes with PBS/2 mM EDTA/0.5% FCS. Cell sorting was
performed with a FACSVantage SE flow cytometer
equipped with a DiVA sort option and an argon-ion laser
at 488 nm excitation wavelength and a laser output of 200
mW (BD Biosciences). A FACSCanto flow cytometer (BD
Biosciences) was used for flow cytometric characterization
of cell populations. The BD FACSDiVa software package
was used for data analysis (BD Biosciences). Purity of
sorted cells was ≥ 98% as determined by flow cytometry
and differential cell counts of Pappenheim (May-Grün-
wald-Giemsa)-stained cytospins.
RNA isolation and cDNA synthesis
After sorting, cells were frozen at -80°C in RLT lysis buffer
(Qiagen) with 1% β-mercaptoethanol (Sigma). RNA from
highly purified cell populations was isolated using an
RNeasy Micro Kit (Qiagen) according to the manufac-
turer's instructions. Quantification and purity of RNA was
determined with an Agilent Bioanalyzer 2100 (Agilent
Biosystems). Only those RNA preparations exceeding
absorbance ratios of A260/280nm  > 1.90 and of a total
amount of RNA greater than 200 ng were used for micro-
array experiments. The cDNA synthesis, reagents and
incubation steps were performed as described previously
[13].
Microarray experiments
A total of 32 animals were used for the microarray experi-
ments. From one mouse, three different cell types, namely
PBMo, Mϕ, and DC, were sorted as outlined above, and
RNA was extracted. In order to get enough RNA for a labe-
ling reaction, RNA was pooled from 4 different extractions
(4 mice, one pool). Two pools of labeled amplified RNA
(aRNA) from different cell types were used per microarray
hybridization (one per dye to reach a balanced dye swap,
see below). The total number of 12 hybridizations were
performed with each 4 hybridizations comparing PBMo
with Mϕ, PBMo with DC, and Mϕ with DC, respectively.
The sample preparation (reverse transcription, T7 RNA
amplification, labeling, purification, hybridization and
subsequent washing and drying of the slides) was per-
formed according to the Two-Color Microarray-Based
Gene Expression Analysis Protocol version 5.5 using the
Agilent Low RNA Input Linear Amplification Kit (Agilent
Technologies, Wilmington, DE). Per reaction, 1 μg of total
RNA was used. The samples were labeled with either Cy3
or Cy5 to match a balanced dye-swap design. The Cy3-
and Cy5-labeled RNA pools were hybridized overnight to
4 × 44 K 60 mer oligonucleotide spotted microarray slidesRespiratory Research 2009, 10:2 http://respiratory-research.com/content/10/1/2
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(Mouse Whole Genome 4 × 44 K; Agilent Technologies).
The dried slides were scanned using a GenePix 4100A
Scanner (Axon Instruments, Downingtown, PA). Image
analysis was performed with GenePix Pro 5.0 software.
Data were evaluated using the R software [14] and the
limma package [15] from BioConductor [16]. The spots
were weighted for subsequent analyses according to the
spot intensity, homogeneity, and saturation. The spot
intensities were corrected for local background using the
method of Edwards [17] with an offset of 64 to stabilize
the variance of low-intensity spots. The M/A data were
LOESS normalized [18] before averaging. Genes were
ranked for differential expression using a moderated t-sta-
tistic [19]. Statistics were obtained by extracting the con-
trasts of interest after fitting an overall model to the entire
dataset. Candidate lists were created by selecting genes
with more than a two-fold difference in expression by
keeping a false-discovery rate of 10%. The adjustment for
multiple testing was done with the method of Benjamini
and Hochberg [20]. Pathway analyses were performed
using Pathway-Express from Onto-Tools [21]. The com-
plete data set is accessible online in the GEO database
http://www.ncbi.nlm.nih.gov/geo/ under the accession
number GSE13558.
Validation of genes by quantitative real time RT-PCR
To validate the results obtained by microarray, RNA tran-
scripts of selected genes were analyzed on independently
sorted samples by qRT-PCR using the ΔCT method for the
calculation of relative changes [22]. The beta-actin and
gapDH genes were confirmed by qRT-PCR to be ubiqui-
tously and consistently expressed genes among the differ-
ent cell types analyzed in this study (data not shown), and
their averaged expression was used as reference gene. The
qRT-PCR analysis was performed with a Sequence Detec-
tion System 7900 (PE Applied Biosystems). Reactions
(final volume: 25 μl) were set up with the SYBR™Green
PCR Core Reagents (Invitrogen), 5 μl cDNA sample and
45 pmol forward (f) and reverse (r) primers. The intron-
spanning primer sequences used were: Itgam, 5'-GGA
CTC TCA TGC CTC CTT TG-3' (f), 5'-ACT TGG TTT TGT
GGG TCC TG-3' (r); Itgb3, 5'-GTC CGC TAC AAA GGG
GAG AT-3' (f), 5'-TAG CCA GTC CAG TCC GAG TC-3' (r);
Itgb7, 5'-GAG GAC TCC AGC AAT GTG GT-3' (f), 5'-GGG
AGT GGA GAG TGC TCA AG-3' (r); Itga4, 5'-TTC GGA
AAA ATG GAA AGT GG-3' (f), 5'-AAC TTT TGG GTG TGG
CTC TG-3' (r); Itgae, 5'-TGG CTC TCA ATT ATC CCA GAA-
3' (f), 5'-CAT GAC CAG GAC AGA AGC AA-3' (r);
Adamts2, 5'-AGT GGG CCC TGA AGA AGT G-3' (f), 5'-
CAG AAG GCT CGG TGT ACC AT-3' (r); Adam19, 5'-GCT
GGT CTC CAC CTT TCT GT-3' (f), 5'-CAG AAC TGC CAA
CAC GAA GA-3' (r); Adam23, 5'-GCT CCA CGT ATC GGT
CAA CT-3' (f), 5'-CCC ACG TCT GTA TCA TCG TCT-3' (r);
Mmp12, 5'-TGA TGC AGC TGT CTT TGA CC-3' (f), 5'-
GTG GAA ATC AGC TTG GGG TA-3' (r); Mmp13, 5'-ATC
CCT TGA TGC CAT TAC CA-3' (f), 5'-AAG AGC TCA GCC
TCA ACC TG-3' (r); Mmp14, 5'-GCC CAA TGG GAA GAC
CTA CT-3' (f), 5'-AGG GTA CTC GCT GTC CAC TG-3' (r);
Mmp19, 5'-TCC AGT GAC TGC AAA ACC TG-3' (f), 5'-
AGT CGC CCT TGA AAG CAT AA-3' (r); Ccl2, 5'-AGC ATC
CAC GTG TTG GCT C-3' (f), 5'-CCA GCC TAC TCA TTG
GGA TCA T-3' (r); Ccr2, 5'-TCT TTG GTT TTG TGG GCA
ACA-3' (f), 5'-TCA GAG ATG GCC AAG TTG AGC-3' (r);
Ccl5, 5'-CTG CTT TGC CTA GGT CTC CCT-3' (f), 5'-CGG
TTC CTT CGA GTG ACA AAC-3' (r); Ccr7, 5'-GTG GTG
GCT CTC CTT GTC AT-3' (f), 5'-GAA GCA CAC CGA CTC
GTA CA-3' (r); IL-18, 5'-CTG GCT GTG ACC CTC TCT GT-
3' (f), 5'-CTG GAA CAC GTT TCT GAA AGA AT-3' (r);
beta-actin, 5'-ACC CTA AGG CCA ACC GTG A-3' (f), 5'-
CAG AGG CATA CAG GGA CAG CA-3' (r); GapDH, 5'-
TGG TGA AGG TCG GTG TGA AC-3' (f), 5'-TGA ATT TGC
CGT GAG TGG AG-3' (r). Data analysis and statistics were
performed using the R program. All data are displayed as
mean values ± SD. Statistical differences between treat-
ment groups were estimated by ANOVA with Turkey's post
hoc test for multiple comparisons. Differences were con-
sidered statistically significant when p values were < 0.05.
Results
Immunophenotypic identification and high purity isolation 
of PBMo, lung DC and lung M  used for transcriptome 
profiling
For high purity sorting, PBMo were identified as SSClow,
CD11bpos, M-CSF receptor/CD115pos cells following pre-
viously reported protocols [23] (Fig. 1A). The cells defined
by this approach homogenously expressed the monocyte
marker F4/80, and were partially positive for GR-1 and
CD11c, with low levels or absence of MHC class II expres-
sion, thereby exhibiting the typical phenotype of PBMo
[23]. In contrast, no expression of T cell, B cell or NK cell
markers (CD3, CD19, and NK1.1, respectively) was
detected (Fig. 1B).
For high purity separation of Mϕ a n d  D C  f r o m  l u n g
homogenates, in a first step the CD11cpos cell fraction was
isolated from lung homogenates using magnetic bead sep-
aration as outlined in the Materials and Methods section.
Within this cell population, lung DC were identified as
CD11cpos, low autofluorescent cells in the FL1 channel,
while lung Mϕ were discriminated as CD11cpos, high FL1
autofluorescent cells (Fig. 2A). Further phenotyping of
accordingly gated subsets revealed the characteristic
marker profiles of lung DC and Mϕ, with lung DC display-
ing a MHC IIhigh CD80low CD86low F4/80low phenotype
and lung Mϕ displaying a MHC IIlow CD80low CD86neg F4/
80pos phenotype (Fig. 2B), which were in line with previ-
ously published results [8,11]. Lung DC primarily exhib-
ited an immature phenotype, as defined by high
expression of MHCII and intermediate expression of the
co-stimulatory molecules CD80 and CD86 (Fig. 2B). Nei-Respiratory Research 2009, 10:2 http://respiratory-research.com/content/10/1/2
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ther an expression of CD115 nor of neutrophil, T cell, B
cell, or NK cell markers was detected (Fig. 2B). The purity
of sorted cells used for the microarray experiments
(PBMo, lung DC and lung Mϕ) was assessed by flow
cytometry and Pappenheim-stained cytospins and was
always ≥ 98%. As sample processing may alter the gene
expression profile of primary cells [24], every effort was
made to minimize processing time and, where possible,
all procedures were performed on ice.
Differentially expressed genes between PBMo, lung DC 
and lung M
After cell sorting and RNA isolation, gene expression pro-
files of PBMo, lung DC and lung Mϕ were compared by
DNA microarray on a whole genome scale. For each com-
parison, four hybridizations were performed. Genes that
exhibited a greater than two-fold change in expression
were considered as being differentially expressed, as
described in the Materials and Methods section. Among
the genes differentially expressed between lung Mϕ and
PBMo, 1530 genes were up-regulated, and 1440 genes
were down-regulated. Comparing lung DC and PBMo,
1271 genes were up-regulated, and 341 were down-regu-
lated. Furthermore, 832 genes were found to be up-regu-
lated and 1565 genes down-regulated between lung Mϕ
and DC. An analysis of the correlation of the M values for
the regulated genes from the different hybridizations
showed a high correlation with an average Pearson corre-
lation coefficient of 0.95, indicating a high consistency
between the four hybridizations per group. In a pathway
analysis, using Pathway-Express from Onto-Tools, the cell
adhesion molecule pathway was the most differentially
regulated pathway in all comparisons. The antigen presen-
tation and processing pathway was the second most dif-
ferentially regulated pathway comparing lung Mϕ versus
DC and DC versus PBMo.
To further analyze and structure the microarray data, and
to address the question of which gene clusters and cellular
pathways are regulated during the extravasations and lung
tissue differentiation process of mononuclear phagocytes,
particular attention was paid to genes involved in cell traf-
ficking, namely integrins, metallopeptidases, chemokines
and chemokine receptors, as well as interleukins and
interleukin receptors (Table 1). In order to visualize the
results, volcano plots were created with depicted genes
belonging to each cluster (Fig. 3). The highlighted genes
were validated on independently sorted samples by qRT-
PCR and demonstrated the same expression trends as the
microarray results (Fig. 4, 5, 6). It must be noted, how-
ever, that the log intensity ratios (i.e. the coefficients dis-
played in Table 1) obtained from the microarray
experiments after RNA preamplification do not directly
equal the ΔCt values obtained from the qRT-PCR valida-
tion. This is a well-known phenomenon and due to partly
not well understood factors such as the preamplification
procedure itself and the limited dynamic range of fluores-
cence detection [25,26]. Due to this, ΔCt values obtained
from the qRT-PCR analysis were often found to be higher
than the coefficients for the same genes obtained from the
microarray analysis. Likewise, by qRT-PCR analysis there
were significant expression differences detectable in cer-
Identification and characterization of PBMo by flow cytome- try Figure 1
Identification and characterization of PBMo by flow 
cytometry. A) Peripheral blood was obtained from 
untreated mice as described, subjected to erythrolysis, and 
analyzed by flow cytometry. PBMo were identified as low 
side scatter (SSC) cell population showing a cell surface 
expression of CD11b and CD115. B) The cell surface anti-
gen distribution profile of PBMo was characterized by flow 
cytometry. PBMo were gated as displayed in (A). Open his-
tograms indicate specific fluorescence of the respective anti-
gen; shaded histograms represent control stained cells. Note 
that all cells displayed F4/80 expression, but were negative 
for GR-1, CD3, CD19, B220/CD45R, and NK1.1, thus 
excluding contamination by neutrophils, T cells, B cells, or 
NK cells, respectively. Displayed data are representative of 
three independent experiments.
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Identification and characterization of lung Mϕ and DC by flow cytometry Figure 2
Identification and characterization of lung Mϕ and DC by flow cytometry. A) CD11c positive cells were obtained 
from lung homogenate by magnetic bead isolation, stained for CD11c, and analyzed by flow cytometry. Lung DC and lung Mϕ 
were differentiated by CD11c expression and autofluorescence with lung DC displaying a low autofluorescence and lung Mϕ 
displaying a high autofluorescence in the FL1 channel. B) The cell surface antigen distribution profiles of lung Mϕ and lung DC 
were analyzed by flow cytometric analysis. Lung Mϕ and DC were gated as displayed in (A). Open histograms indicate specific 
fluorescence of the respective antigen; shaded histograms represent control stained cells. Displayed data are representative of 
three independent experiments.
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Table 1: Most strongly and significantly regulated genes belonging to selected gene clusters.
gene symbol gene description coefficient
MΦ vs PBMo DC vs PBMo MΦ vs DC
metallopeptidases
Mmp19 matrix metallopeptidase 19 [NM_021412] 1,99 ND 2,0
Mmp13 matrix metallopeptidase 13 [NM_008607] ND 3,81 ND
Adam23 disintegrin and metallopeptidase domain 23 [NM_011780] ND 3,02 ND
Mmp14 matrix metallopeptidase 14 [NM_008608] ND 2,61 -2,6
Adam8 disintegrin and metallopeptidase domain 8 [NM_007403] ND 2,50 -3,7
Mmp12 matrix metallopeptidase 12 [NM_008605] ND 2,39 ND
Mmp8 matrix metallopeptidase 8 [NM_008611]N D - 2 , 7 4 N D
Adam19 disintegrin and metallopeptidase domain 19 [NM_009616]N D N D - 2 , 1
Mmp13 matrix metallopeptidase 13 [NM_008607]N D N D - 2 , 7
Adamts2 disintegrin-like and metallopeptidase 3,65 ND ND
with thrombospondin type 1 motif [NM_175643]
chemokine/chemokine receptor
Cxcl1 chemokine (C-X-C motif) ligand 1 [NM_008176] 5,69 4,45 ND
Cxcl2 chemokine (C-X-C motif) ligand 2 [NM_009140] 4,76 ND ND
Cx3cl1 chemokine (C-X3-C motif) ligand 1 [NM_009142] 4,09 4,37 ND
Ccl6 chemokine (C-C motif) ligand 6 [NM_009139] 2,70 ND 2,6
Ccl17 chemokine (C-C motif) ligand 17 [NM_011332] 2,68 4,38 ND
Ccrl2 chemokine (C-C motif) receptor-like 2 [NM_017466] 2,35 ND ND
Ccl3 chemokine (C-C motif) ligand 3 [NM_011337] 2,25 ND ND
Cxcl10 chemokine (C-X-C motif) ligand 10 [NM_021274] 2,06 ND ND
Ccl2 chemokine (C-C motif) ligand 2 [NM_011333] 2,04 2,44 ND
Ccl9 chemokine (C-C motif) ligand 9 [NM_011338] -2,07 ND ND
Cxcl4 chemokine (C-X-C motif) ligand 4 [NM_019932] -2,38 ND -2,8
Cx3cr1 chemokine (C-X3-C) receptor 1 [NM_009987] -3,36 ND -2,7
Ccl5 chemokine (C-C motif) ligand 5 [NM_013653] -3,72 ND -5,9
Cxcl7 chemokine (C-X-C motif) ligand 7 [NM_023785] -4,68 -3,42 ND
Ccr2 chemokine (C-C motif) receptor 2 [NM_009915] -4,70 -2,04 -2,7
Ccr7 chemokine (C-C motif) receptor 7 [NM_007719] ND 4,61 -4,4
Cxcl16 chemokine (C-X-C motif) ligand 16 [NM_023158] ND 4,17 -2,6
Ccl4 chemokine (C-C motif) ligand 4 [NM_013652] ND 4,09 -3,3
Ccl12 chemokine (C-C motif) ligand 12 [NM_011331] ND 2,72 ND
Cxcr3 chemokine (C-X-C motif) receptor 3 [NM_009910] ND 2,55 -4,2
Cxcr4 chemokine (C-X-C motif) receptor 4 [NM_009911] ND 2,51 -2,6
Ccr9 chemokine (C-C motif) receptor 9 [NM_009913] ND 2,45 -2,5
Ccl7 chemokine (C-C motif) ligand 7 [NM_013654] ND 2,26 ND
Cxcr6 chemokine (C-X-C motif) receptor 6 [NM_030712]N D N D - 2 , 6
interleukin/interleukin receptor
Il1a interleukin 1 alpha [NM_010554] 4,21 2,25 2,2
Il6 interleukin 6 [NM_031168] 4,18 ND ND
Il18 interleukin 18 [NM_008360] 3,04 ND 2,6
Il17d interleukin 17D [NM_145837] 2,69 ND ND
Il1b interleukin 1 beta [NM_008361] 2,18 3,84 ND
Il11ra1 interleukin 11 receptor, alpha chain 1 [NM_010549] 2,09 ND ND
Il2rb interleukin 2 receptor, beta chain [NM_008368] -3,14 ND -5,1
Il12b interleukin 12b [NM_008352] ND 3,92 -2,5
Il7r interleukin 7 receptor [NM_008372] ND 2,87 -2,7
Il6 interleukin 6 [NM_031168] ND 2,82 ND
Il18r1 interleukin 18 receptor 1 [NM_008365]N D N D - 3 , 3Respiratory Research 2009, 10:2 http://respiratory-research.com/content/10/1/2
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tain genes that had not been detected by the array experi-
ments (Table 1 and Fig. 4, 5, 6).
Isolation and gene expression profiling of subpopulations 
of PBMo and lung M
The microarray experiments described above were
designed to compare the gene expression profiles of PBMo
and their fully differentiated pulmonary progeny lung DC
and lung Mϕ on a genome-wide scale. This approach,
however, does not detect potential differences in gene
expression between intermediate differentiation stages or
distinct subpopulations of circulating or lung tissue
mononuclear phagocytes, which have been ascribed dif-
ferent migratory and differentiation properties. Thus, the
two dominant subpopulations of PBMo, the "inflamma-
tory" (GR-1pos) and the "resident" (GR-1neg) subsets, have
been attributed with different biological functions,
including recruitment under inflammatory versus steady-
state conditions, and differentiation into functionally dif-
ferent DC and Mϕ populations [5,27]. To further identify
possible differences in the expression profiles of the
selected genes, GR-1high and GR-1low PBMo were sorted for
qRT-PCR analysis based on the expression of CD11b,
CD115 and GR-1, as depicted in Fig. 7A. Like PBMo, lung
Mϕ can be divided into two major populations according
to their anatomical location, the parenchymal or intersti-
tial Mϕ (iMϕ), and the resident alveolar macrophages
(rAM). Whether these populations represent functionally
different subpopulations has long been a matter of
debate. Recent reports, however, indicate a functional and
developmental difference, with the iMϕ being proposed
as precursor cells for rAM [28]. For the separation of rAM,
BALF was obtained from mouse lungs, and rAM were
flow-sorted from the lavage by gating the high FL1
autofluorescent, CD11cpos cell population (Fig. 7B). By
lavaging one can remove > 90% of the alveolar macro-
phages from mouse lungs [29]. In the current experi-
ments, the lavage procedure depleted rAM efficiently from
the lungs thus enriching the iMϕ subset, following an
approach used by Landsman et al. [6,28]. No additional
integrins
Itgax integrin alpha X [NM_021334] 2,39 2,25 ND
Itga2b integrin alpha 2b [NM_010575] -2,02 ND ND
Itgam integrin alpha M [NM_008401] -2,11 ND -2,1
Itga4 integrin alpha 4 [NM_010576] -2,63 ND -2,3
Itgb7 integrin beta 7 [NM_013566] -3,76 ND -3,5
Itgae integrin, alpha E, epithelial-associated [NM_008399] ND 3,88 -3,1
Itgb3 integrin beta 3 [AK135584] -3,64 ND -2,8
Genes were selected to keep a false-discovery rate of 10%. Genes are indicated by their consensus name and the NCBI GenBank accession number 
given in square brackets. The coefficient given for the expression corresponds to log2 of fold change with a coefficient >0 indicating upregulation 
and a coefficient <0 indicating downregulation of the respective gene. Absence of a differential regulation between the respective groups is indicated 
by ND.
Table 1: Most strongly and significantly regulated genes belonging to selected gene clusters. (Continued)
Volcano plot representation of microarray data Figure 3
Volcano plot representation of microarray data. Gene expression profiles of A) lung Mϕ versus PBMo, B) lung DC ver-
sus PBMo, and C) lung Mϕ versus lung DC were plotted according to the log2 fold change (X axis) and log10unadjusted p-value 
(Y axis). The genes for which the expression has been validated by qRT-PCR are highlighted. Data are representative of four 
hybridizations per group.
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Validation of metalloproteinase genes by qRT-PCR Figure 4
Validation of metalloproteinase genes by qRT-PCR. PBMo, lung Mϕ and DC were sorted as shown in Fig. 1A and 2A. 
mRNA expression was assessed by qRT-PCR analysis for metalloproteinases. Data are presented as mean ± SD of 4 independ-
ent experiments per group. All differences between gene expression were statistically significant with p < 0.05 except where 
indicated by n.s. (not significant). A non-detectable gene expression is indicated by n.d. (not detected).
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rAM could be obtained by serial lavage, indicating an effi-
cient lavaging procedure. Enriched interstitial Mϕ and DC
were then isolated from homogenates obtained from lav-
aged lungs (Fig. 7C) using the sorting strategy described
above (Fig. 2A).
The differential expression of selected genes was further
evaluated in the GR-1high and GR-1low subsets of PBMo,
iMϕ and rAM, as well as in lung DC, by qRT-PCR (Fig. 8,
9, 10). Differences in the mRNA expression of all selected
genes were statistically significant, and demonstrated the
same expression trends as the results obtained by microar-
ray experiments (Fig. 8, 9, 10). In addition to microarray
results, new information was obtained with respect to dif-
ferences in gene expression between subpopulations of
PBMo and lung Mϕ. iMϕ and rAM exhibited significantly
different gene expression in 14 out of 17 analyzed genes,
suggesting a functional and/or developmental difference.
Expression levels of Mmps in PBMo subpopulation were
very low or not detectable in qRT-PCR experiments except
Mmp14, Mmp19 and Adam19 (Fig. 8). Expression of
Mmp19 and Adamts2 did not differ between iMϕ and
rAM, but both genes exhibited elevated expression com-
pared to DC. All other Mmps examined exhibited higher
expression levels in DC in comparison to iMϕ and rAM.
The GR-1high and GR-1low PBMo subsets did not differ in
integrin expression, but significant differences were
observed in all other genes analyzed, especially with
respect to chemokine and chemokine receptor expression,
confirming and expanding previous reports. The expres-
sion profile of lung DC was essentially similar to the
Validation of chemokine and interleukin genes byqRT-PCR Figure 5
Validation of chemokine and interleukin genes 
byqRT-PCR. PBMo, lung Mϕ and DC were sorted as shown 
in Fig. 1A and 2A. mRNA expression was assessed by qRT-
PCR analysis for chemokines and interleukins. Data are pre-
sented as mean ± SD of 4 independent experiments per 
group. All differences between gene expression were statisti-
cally significant with p < 0.05 except where indicated by n.s. 
(not significant).
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Validation of integrin genes by qRT-PCR Figure 6
Validation of integrin genes by qRT-PCR. PBMo, lung 
Mϕ and DC were sorted as shown in Fig. 1A and 2A. mRNA 
expression was assessed by qRT-PCR analysis for integrins. 
Data are presented as mean ± SD of 4 independent experi-
ments per group. All differences between gene expression 
were statistically significant with p < 0.05 except where indi-
cated by n.s. (not significant).
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expression profiles of PBMo subpopulations, while lung
Mϕ subpopulations significantly differed.
Confirmation of selected integrin expression by flow 
cytometry on subsets of PBMo and lung M , and lung 
dendritic cells
To further assess whether transcript levels demonstrated
the same protein expression pattern, the integrins exam-
ined by qRT-PCR on mononuclear phagocyte populations
(Fig. 10) were also assessed for cell surface expression by
quantitative flow cytometry (Fig. 11). The cell surface
expression levels of the respective integrin molecules
demonstrated the same expression trends as the observed
mRNA levels in the mononuclear phagocyte subsets ana-
lyzed. In particular, iMϕ and rAM lose expression of most
selected integrins, except integrin α M, which was partially
expressed by iMϕ, but was not present in rAM. In contrast,
integrin β1, β2 and β3 expression remains high in lung
DC. Integrin αE was expressed exclusively on a lung DC
subset, and its expression pattern was identical to the
expression of integrin β7, suggesting co-expression of
integrins αE and β7 on subpopulation of DC, which has
previously been described [30].
Discussion
The constant maintenance of both DC and Mϕ cell pools
in the lung is essential for effective immune surveillance
in pulmonary tissue. Recent reports highlight the role of
PBMo that emigrate into the lung and differentiate into
both lung DC and Mϕ, thereby serving as a constant sup-
ply for the renewal of the lung DC and Mϕ pool [6]. While
many studies have investigated monocyte recruitment
under inflammatory conditions, little is known about the
pathways mediating monocyte trafficking and differentia-
tion in lung tissue under non-inflammatory conditions
[27,31,32]. Since PBMo are believed to be precursors for
lung Mϕ and DC, a global gene expression profiling
approach was chosen to reveal crucial differences between
these cell types, to better understand their relation to one
another, and to identify gene clusters relevant for the
migration and differentiation process that takes place
under steady-state conditions. Previous microarray stud-
ies investigating the relation, differentiation and/or matu-
ration of monocytes, macrophages and DC have been
mainly conducted in vitro using both murine and human
cells [33-35]. A study comparing primary human AM ver-
sus AM differentiated in vitro from PBMo has demon-
strated significant differences in gene expression profiles
[36], indicating the necessity of carefully elaborating the
differences and similarities between in vivo and in vitro dif-
ferentiation. A recent publication from our group com-
pared gene expression profiles of murine mononuclear
phagocytes recruited to the alveolar space under non-
inflammatory and inflammatory conditions using 1 K
nylon arrays [37]. The present study was undertaken as
the first in vivo investigation using cell specific whole
genome expression profiling of key players in lung immu-
nity, namely lung Mϕ and lung DC and their circulating
precursors PBMo, to define the gene expression differ-
ences between these three cell populations under non-
inflammatory conditions in mice. By this, it could be
demonstrated that approximately 5–10% of all genes are
differentially regulated between these three cell popula-
tions which are closely related with respect to origin, des-
tination and function. Whether these expression
differences represent preformed, lineage-specific differen-
tiation programs or are rather due to the interaction of
Isolation strategy of subpopulations of PBMo and lung Mϕ Figure 7
Isolation strategy of subpopulations of PBMo and 
lung Mϕ. A) PBMo were flow-sorted from peripheral blood 
leukocytes by gating on the low SSC/CD11bpos/CD115pos 
population, as shown in Fig. 1. Additional gates were set on 
the GR-1-positive (PBMo GR-1high) and GR-1-negative 
(PBMo GR-1low) subsets of PBMo. B) Resident alveolar mac-
rophages (rAM) were flow-sorted from BAL fluid by gating 
on the high FSC/high SSC/CD11cpos/high autofluorescent cell 
population. C) After BAL, lungs were removed, and 
CD11cpos cells were isolated from lung homogenate using 
magnetic beads as described. Subsequently, CD11cpos cells 
from lung homogenate were flow-sorted for the low autoflu-
orescent population representing lung DC and the high 
autofluorescent population representing Mϕ as described. 
Note that the majority of rAM had been removed from lungs 
by lavage prior to homogenization, and that the flow-sorted 
Mϕ mainly represent interstitial Mϕ (iMϕ). Displayed data are 
representative of 5–6 independent sorting experiments per 
group.
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Relative mRNA expression of metalloproteinase genes by qRT-PCR Figure 8
Relative mRNA expression of metalloproteinase genes by qRT-PCR. GR-1high and GR-1low PBMo, iMϕ and rAM as 
well as lung DC were sorted as shown in Fig. 5, and mRNA expression was assessed by qRT-PCR analysis. Data are presented 
as mean ± SD of 4 independent experiments per group. All differences between gene expression were statistically significant 
with p < 0.05 except where indicated by n.s. (not significant). A non-detectable gene expression is indicated by n.d. (not 
detected). Mo-, GR-1low PBMo; Mo+, GR-1high PBMo; iMϕ, interstitial lung macrophage; rAM, resident alveolar macrophage.
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migrating PBMo and specific micro-environmental factors
of the lung must be addressed in detail in subsequent
studies.
The gene expression patterns obtained from our study
suggest that lung DC are phenotypically closer related to
PBMo than lung tissue Mϕ. When further comparing the
transcriptional regulation of selected genes in the lung
macrophage subpopulations iMϕ and rAM by qRT PCR,
the transcripts of CCR2, CCL2, CCR7 and CD61 all highly
expressed in PBMo were found to be less downregulated
in iMϕ compared to rAM. This finding supports a recent
report by Landsman et al., suggesting that iMϕ are an
intermediate stage in the differentiation process to rAM
[28].
An important issue when interpreting DNA microarray
data is whether mRNA expression levels demonstrates the
same expression trends as the expression of the encoded
proteins. Notably, the transcriptional expression patterns
of selected integrins obtained by DNA array and qRT-PCR
were found to demonstrete the same expression trend as
the expression levels of the respective proteins on the cell
surface as detected by flow cytometry.
Lung DC and Mϕ play diverse functional roles in innate
immunity, and their localization to different compart-
ments of the lung suggests different migration properties
of these cell types. Under steady-state conditions, DC
largely reside in the interstitial compartment, with only
minor parts located in the alveolar space, and ultimately
they emigrate to the thoracic lymph nodes to present anti-
gen to T cells. Conversely, Mϕ readily pass through the
epithelial barrier and enter the alveolar airspaces, which
very likely represents a terminal destination. Hypothesiz-
ing that DC and rAM residing in different environments
Relative mRNA expression of chemokine and interleukin  genes by qRT-PCR Figure 9
Relative mRNA expression of chemokine and inter-
leukin genes by qRT-PCR. GR-1high and GR-1low PBMo, 
iMϕ and rAM as well as lung DC were sorted as shown in Fig. 
5, and mRNA expression was assessed by qRT-PCR analysis. 
Data are presented as mean ± SD of 4 independent experi-
ments per group. All differences between gene expression 
were statistically significant with p < 0.05 except where indi-
cated by n.s. (not significant). Mo-, GR-1low PBMo; Mo+, GR-
1high PBMo; iMϕ, interstitial lung macrophage; rAM, resident 
alveolar macrophage.
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Relative mRNA expression of integrin genes byqRT-PCR Figure 10
Relative mRNA expression of integrin genes byqRT-
PCR. GR-1high and GR-1low PBMo, iMϕ and rAM as well as 
lung DC were sorted as shown in Fig. 5, and mRNA expres-
sion was assessed by qRT-PCR analysis. Data are presented 
as mean ± SD of 4 independent experiments per group. All 
differences between gene expression were statistically signifi-
cant with p < 0.05 except where indicated by n.s. (not signifi-
cant). Mo-, GR-1low PBMo; Mo+, GR-1high PBMo; iMϕ, 
interstitial lung macrophage; rAM, resident alveolar macro-
phage.
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most likely require different migration and tissue invasion
capacities, differentially expressed genes were grouped
into trafficking related clusters such as integrins, Mmps,
chemokine and chemokine receptors, and interleukins
and interleukin receptors. Integrins are key mediators of
cell-cell interactions, and given their different tissue local-
ization, DC and Mϕ most likely have to interact with dif-
ferent cell types or the extracellular matrix (ECM). Indeed,
the paucity of integrin gene expression in rAM as com-
pared to PBMo and lung DC suggests that rAM require less
integrin-mediated cell-cell communication, which is con-
sistent with the view of rAM being confined to the alveolar
Confirmation of the expression pattern of differentially regulated integrins with flow cytometry Figure 11
Confirmation of the expression pattern of differentially regulated integrins with flow cytometry. GR-1-positive 
(PBMo GR-1high) and GR-1-negative (PBMo GR-1low) subsets of PBMo, lung interstitial (iMϕ) and alveolar (rAM) macrophages, 
and lung dendritic cells (DC) were isolated as described and analyzed by flow cytometry for the expression of the indicated 
integrins. Gates on the respective cell populations were set as illustrated in Fig. 4. Open histograms indicate specific fluores-
cence of the indicated antigen; shaded histograms represent control stained cells. Displayed data are representative of three 
independent experiments.
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space, rather than possessing extensive migratory proper-
ties. Members of the MMP family can cleave components
of the ECM, thereby facilitating cell migration [38]. Fur-
thermore, Mmps can modulate the activity of chemokines
[39], cytokines [40], and selectins [41]. Chemokines
themselves also regulate Mmps and integrin avidity [42-
44]. The different biological functions of DC and Mϕ
would imply that these cell types have different interac-
tions with their direct environment, suggesting the differ-
ential expression of genes that regulate cell interaction
with the ECM, and responses to chemokines and
cytokines. Our data show that DC and Mϕ express differ-
ent clusters of MMP as well as cytokine and chemokine
receptor genes, indicating distinct patterns of migration
properties.
It has previously been shown that Mmp2 and Mmp9 are
critically required by DC for recruitment to the airways in
a murine model of asthma [45] and for the migration of
DC from the skin to lymph nodes [46]. While a difference
in gene expression of Mmp2 and Mmp9 between lung DC
and lung Mϕ could not be demonstrated by microarray,
five members of the Mmp family, Adam19, Adam23,
Mmp12, Mmp13 and Mmp14 were identified, which
were dramatically upregulated in lung DC versus Mϕ,
while Mmp19 was upregulated in both iMϕ and rAM,
compared to DC. In contrast, expression of Mmps except
Mmp8, Mmp19 and Adam19 in PBMo was low or not
detectable, indicating that the transcriptional upregula-
tion of these highly active enzymes is an important and
immediate step in the differentiation process after PBMo
emigration from the blood into the lung. However, the
exact role played by these differentially expressed mem-
bers of the Mmp family in cell migration, phagocytosis
and antigen processing has to be further delineated. Sim-
ilarly, the mechanisms by which Mmps regulate the func-
tion of chemokines, cytokines, and integrin expression,
which influence DC and Mϕ migration and activity, also
await elucidation. Another important aspect of this study
is the detailed delineation of the expression pattern of
chemokines and their receptors in PBMo, lung Mϕ and
lung DC under non-inflammatory conditions. The micro-
array and qRT-PCR analyses demonstrate that all three cell
populations express a variety of both chemokines and
receptors. The qRT-PCR analysis of the mRNA levels in
iMϕ and rAM, however, indicates a more active participa-
tion in chemokine production by the iMϕ than by the
rAM population.
Conclusion
Taken together, to the best of our knowledge, this study is
the first to analyze the gene expression profile of the
major phagocytotic and antigen-presenting cells of the
lung, Mϕ and DC, and their putative precursor cells,
monocytes from peripheral blood, on a whole-genome
scale under non-inflammatory, steady-state conditions.
The diversity of genes differentially regulated in the inves-
tigated clusters was found to be largest in DC correspond-
ing to their volatility and multiple functions in antigen
uptake, processing and subsequent presentation. In addi-
tion, DC preserve the high expression level of integrin and
chemokine/chemokine receptor genes found in PBMo
whereas lung Mϕ display much lower transcript levels of
these traffic related molecules. As previously poorly inves-
tigated players in pulmonary mononuclear phagocyte
function, transcript levels of most members of the Mmp
family were low or not detectable in PBMo, but were
found to be strongly upregulated in both lung DC and
Mϕ, however with a unique expression pattern of distinct
Mmp family members in both cell types potentially
related to cell type specific functions in lung tissue that
has to be delineated in further studies.
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